Evidence-Informed Provision of Doxycycline Post-Exposure Prophylaxis for Prevention of Bacterial Sexually Transmitted Infections

• Published in: Clinical infectious diseases
• Main Authors: Dombrowski, Julia C, Donnell, Deborah, Grabow, Cole, Cohen, Stephanie E, Cannon, Chase A, Brown, Clare E, Buchbinder, Susan P, Celum, Connie, Luetkemeyer, Anne F
• Format: Journal Article
• Language: English
• Published: United States 30.10.2024
• Subjects: HIV; HIV Pre-Exposure Prophylaxis; Delivery of Healthcare; Doxycycline Prophylaxis; Sexually Transmitted Infections
• ISSN: 1537-6591
• DOI: 10.1093/cid/ciae527

Doxycycline post-exposure prophylaxis (doxy-PEP) reduces the risk of bacterial sexually transmitted infections (STIs) among men who have sex with men and transgender women. In the United States, doxy-PEP is in an early stage of integration into clinical practice, and national guidelines for its use were recently released. The goal of this manuscript is to provide practical guidance for clinicians who are considering or currently prescribing doxy-PEP. We address five clinical questions using post hoc analyses of data from the DoxyPEP randomized controlled trial and discuss the potential implications and limitations of each question with the goal of informing clinical practice and implementation of doxy-PEP programs. The questions address patient eligibility criteria for doxy-PEP, the expected benefit and associated doxy-PEP doses for the average patient, the initial number of doses prescribed, and laboratory monitoring of persons taking doxy-PEP.